Related Experiment Video
Updated: Apr 11, 2026

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
Metaplastic carcinoma of the breast
Elizabeth McKinnon1, Philip Xiao
1From the Department of Pathology, The Brooklyn Hospital Center/NewYork-Presbyterian Healthcare System, Brooklyn, New York. Dr McKinnon is currently located at the Department of Pathology, Duke University Medical Center, Durham, North Carolina.
Abstract:
Metaplastic carcinoma of the breast is a rare but aggressive type of breast cancer that has been recognized as a unique pathologic entity by the World Health Organization. Morphologically, it is characterized by the differentiation of neoplastic epithelium into squamous cells and/or mesenchymal-looking elements (squamous cells, spindle cells, cartilage or bone, etc). It shares many similarities with invasive ductal carcinoma and benign lesions on mammography, which further complicates the diagnosis. Treatment for metaplastic breast carcinoma is relatively unknown because of the rarity of the disease, but studies suggest that removal of the tumor and adjuvant radiation therapy has the greatest benefit.

